Literature DB >> 20503007

[Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics].

Miriam Wittek1, Hans Wilhelm Doerr, Regina Allwinn.   

Abstract

Varicella-zoster virus (VZV), known as one of the eight human herpesviridae, shows a ubiquitous distribution and is the cause for acute exanthema in childhood (chickenpox). VZV is highly infectious, spread by respiratory droplets and direct contact with fluid in vesicles. As a characteristic of the alpha-herpesviridae, VZV establishes latency in the nucleus of the paraspinal cells. Reactivation of VZV (zoster) is possible in all infected persons, but becomes more common with increasing age and a decline of VZV-specific cell-mediated immunity. Immunocompromised patients and older people (> 50 years) have an increased risk for a severe course of disease. The postherpetic neuralgia (PHN), as one of the most common and feared complications, is defined as a neuropathic pain (burning character), which persists for > 6 weeks after onset of disease and needs adequate antiviral and pain treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20503007     DOI: 10.1007/s00063-010-1061-3

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  31 in total

1.  Congenital varicella-zoster virus infection and Barrett's esophagus.

Authors:  X T Ussery; P Annunziato; A A Gershon; B S Reid; O Lungu; C Langston; S Silverstein; K K Lee; C J Baker
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

Review 2.  Fetal varicella syndrome--a reappraisal of the literature. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.

Authors:  K Birthistle; D Carrington
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

3.  Seroprevalence of varicella-zoster virus in the German population.

Authors:  P Wutzler; I Färber; S Wagenpfeil; H Bisanz; A Tischer
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

Review 4.  Chickenpox in pregnancy: revisited.

Authors:  Michael Paul Tan; Gideon Koren
Journal:  Reprod Toxicol       Date:  2005-06-23       Impact factor: 3.143

5.  Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.

Authors:  J Colin; O Prisant; B Cochener; O Lescale; B Rolland; T Hoang-Xuan
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

6.  [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].

Authors:  S Buxbaum; H W Doerr; R Allwinn
Journal:  Dtsch Med Wochenschr       Date:  2001-11-16       Impact factor: 0.628

7.  Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases.

Authors:  G Enders; E Miller; J Cradock-Watson; I Bolley; M Ridehalgh
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

Review 8.  Herpes zoster in otherwise healthy children.

Authors:  Henry M Feder; Diane M Hoss
Journal:  Pediatr Infect Dis J       Date:  2004-05       Impact factor: 2.129

9.  Polymerase chain reaction as a rapid diagnostic tool for therapy of acute retinal necrosis syndrome.

Authors:  Franco Gargiulo; Maria Antonia De Francesco; Giuseppe Nascimbeni; Raffaele Turano; Francesca Perandin; Enrico Gandolfo; Nino Manca
Journal:  J Med Virol       Date:  2003-03       Impact factor: 2.327

10.  Outcome after maternal varicella infection in the first 20 weeks of pregnancy.

Authors:  A L Pastuszak; M Levy; B Schick; C Zuber; M Feldkamp; J Gladstone; F Bar-Levy; E Jackson; A Donnenfeld; W Meschino
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more
  8 in total

Review 1.  Preventing vertical virus infections: the role of serologic screening of pregnant women.

Authors:  Annemarie Berger; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2018-07-03       Impact factor: 3.402

2.  Herpes zoster in Germany: quantifying the burden of disease.

Authors:  Bernhard Ultsch; Anette Siedler; Thorsten Rieck; Thomas Reinhold; Gérard Krause; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2011-06-16       Impact factor: 3.090

3.  Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.

Authors:  Bernhard Ultsch; Ingrid Köster; Thomas Reinhold; Anette Siedler; Gérard Krause; Andrea Icks; Ingrid Schubert; Ole Wichmann
Journal:  Eur J Health Econ       Date:  2012-12-28

4.  Seroprevalence of varicella-zoster virus among pregnant women in two teaching hospitals, Tehran, Iran.

Authors:  Mahshid Talebi-Taher; Maryam Kashanian; Katayoon Khalili
Journal:  Iran J Microbiol       Date:  2014-02

5.  Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.

Authors:  Bernhard Ultsch; Felix Weidemann; Thomas Reinhold; Anette Siedler; Gérard Krause; Ole Wichmann
Journal:  BMC Health Serv Res       Date:  2013-09-26       Impact factor: 2.655

6.  Social Phobia Is Associated with Delayed Onset of Chickenpox, Measles, and Mumps Infections.

Authors:  Vladeta Ajdacic-Gross; Aleksandra Aleksandrowicz; Stephanie Rodgers; Mario Müller; Wolfram Kawohl; Wulf Rössler; Enrique Castelao; Caroline Vandeleur; Roland von Känel; Margot Mutsch; Roselind Lieb; Martin Preisig
Journal:  Front Psychiatry       Date:  2016-12-27       Impact factor: 4.157

7.  Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.

Authors:  Enas G Ibrahim; Wafaa Y Abdel Wahed; Hanaa M Eid; Wessam S Deeb
Journal:  J Egypt Public Health Assoc       Date:  2019-01-07

8.  Zoster-associated limb paralysis mimicking acute stroke: a case report.

Authors:  Chamara Dalugama; Ruwanthi Jayasinghe; Nimanthi Rathnayaka; Arjuna Medagama
Journal:  J Med Case Rep       Date:  2021-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.